cityblick24.de – Date: 06.05.2024
Author: cityblick24.de – Source
Novogenia is transforming Germany’s healthcare sector by introducing advanced genetic analysis, replacing traditional treatment methods with personalised health strategies. Under the leadership of Dr. Daniel Wallerstorfer, the company offers tailored care by focusing on unique genetic profiles, promising to redefine patient care through precision and innovation. This personalised medicine approach benefits health professionals across various fields, from nutrition to physiotherapy, urging a shift toward more individualised health solutions.
Founded in 2009 and based in Salzburg, Austria, Novogenia leads in genetic research, providing insights through preventive and lifestyle gene analyses. Their advanced DNA testing technologies, which examine up to 15 million genetic variations per sample, enable the creation of customised nutrition plans, fitness programs, and treatment strategies. With their innovative approach, Novogenia is poised to shape the future of healthcare in Germany, advocating for personalised care as the key to maintaining and improving health standards.
